Related references
Note: Only part of the references are listed.The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value
Esther Janssens et al.
ACTA CLINICA BELGICA (2023)
Early Life Antibiotic Exposure and the Subsequent Risk of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis
Hai-ying Yu et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2022)
Immunization in pregnancy to protect pregnant people and their newborns against COVID-19
Mahin Delara et al.
EXPERT REVIEW OF VACCINES (2022)
Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021
Peter B. Gilbert et al.
VACCINE (2022)
The urgent need to recognize and properly address prenatal-onset group B Streptococcus disease
Natalia Silva Costa et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)
Effectiveness of oral intake of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on Group B Streptococcus colonization during pregnancy: a midwifery-led double-blind randomized controlled pilot trial
Mary Sharpe et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2021)
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial
Judith Absalon et al.
LANCET INFECTIOUS DISEASES (2021)
Group B streptococcus vaccines: one step further
Reinhard Berner
LANCET INFECTIOUS DISEASES (2021)
Serotype distribution and incidence of invasive early onset and late onset group B streptococcal disease amongst infants in Singapore
Kai-Qian Kam et al.
BMC INFECTIOUS DISEASES (2021)
Early life exposure to antibiotics and the risk of mood and anxiety disorders in children and adolescents: A population-based cohort study
Mahin Delara et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Evidence for causal associations between prenatal and postnatal antibiotic exposure and asthma in children, England
Sergio Souza da Cunha et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2021)
Bacterial and Host Determinants of Group B Streptococcal Vaginal Colonization and Ascending Infection in Pregnancy
Alyssa Brokaw et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Understanding Factors in Group B Streptococcus Late-Onset Disease
Alberto Berardi et al.
INFECTION AND DRUG RESISTANCE (2021)
Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study
Erzsebet Horvath-Puho et al.
LANCET CHILD & ADOLESCENT HEALTH (2021)
Vaccination during pregnancy: current and possible future recommendations
Kirsten Maertens et al.
EUROPEAN JOURNAL OF PEDIATRICS (2020)
A Vaccine Against Group B Streptococcus: Recent Advances
Clara Carreras-Abad et al.
INFECTION AND DRUG RESISTANCE (2020)
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial
Geeta K. Swamy et al.
VACCINE (2020)
Oral probiotics to reduce vaginal group B streptococcal colonization in late pregnancy
Alex Farr et al.
SCIENTIFIC REPORTS (2020)
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations
Johan Vekemans et al.
VACCINE (2019)
Group B Streptococcus: Trials and Tribulations
Hannah G. Davies et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2019)
The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease
Gabrielle Nicole Gaultier et al.
BMC IMMUNOLOGY (2019)
Characterisation of bone and joint infections due to Group B Streptococcus serotype III sequence type 283
Sean W. Ong et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women
Monica Fabbrini et al.
JOURNAL OF INFECTION (2018)
The impact of oral probiotics on vaginal Group B Streptococcal colonisation rates in pregnant women: A pilot randomised control study
Paula Olsen et al.
WOMEN AND BIRTH (2018)
Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches
Kathryn A. Patras et al.
FRONTIERS IN PEDIATRICS (2018)
Genetic evidence for a novel variant of the pilus island 1 backbone protein in group B Streptococcus
Sarah Teatero et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2017)
Epidemiology of Late and Very Late Onset Group B Streptococcal Disease Fifteen-Year Experience From Two Australian Tertiary Pediatric Facilities
Adam W. Bartlett et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies
Jay Vornhagen et al.
TRENDS IN MICROBIOLOGY (2017)
Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities
Amy Grenham et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis
Piet Cools et al.
SCIENTIFIC REPORTS (2017)
Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy
Shabir A. Madhi et al.
CLINICAL INFECTIOUS DISEASES (2017)
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses
Lola Madrid et al.
CLINICAL INFECTIOUS DISEASES (2017)
Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses
Maya Kohli-Lynch et al.
CLINICAL INFECTIOUS DISEASES (2017)
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial
Robert S. Heyderman et al.
LANCET INFECTIOUS DISEASES (2016)
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial
Shabir A. Madhi et al.
LANCET INFECTIOUS DISEASES (2016)
Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine A Randomized Controlled Trial
Gilbert G. G. Donders et al.
OBSTETRICS AND GYNECOLOGY (2016)
Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: A randomized controlled trial
Ming Ho et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2016)
Increased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible Mechanisms
Nicolas Dauby et al.
FRONTIERS IN IMMUNOLOGY (2016)
Ethical considerations for designing GBS maternal vaccine efficacy trials in low-middle income countries
Amina White et al.
VACCINE (2015)
Structure and Assembly of Group B Streptococcus Pilus 2b Backbone Protein
Roberta Cozzi et al.
PLOS ONE (2015)
Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates
Jeffrey W. Eaton et al.
AIDS (2014)
Early-Onset Neonatal Sepsis
Kari A. Simonsen et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Feasibility of Oral Prenatal Probiotics against Maternal Group B Streptococcus Vaginal and Rectal Colonization
Lisa Hanson et al.
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING (2014)
Maternal Antibody at Delivery Protects Neonates From Early Onset Group B Streptococcal Disease
Carol J. Baker et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Safety of immunization during pregnancy: A review of the evidence of selected inactivated and live attenuated vaccines
Brigitte Keller-Stanislawski et al.
VACCINE (2014)
The Prevention of Early-Onset Neonatal Group B Streptococcal Disease
Deborah Money et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2013)
Capsular Switching in Group B Streptococcus CC17 Hypervirulent Clone: A Future Challenge for Polysaccharide Vaccine Development
Samuel Bellais et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis
Karen M. Edmond et al.
LANCET (2012)
T cell-independent B cell memory
Thierry Defrance et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules
Ray Borrow et al.
EXPERT REVIEW OF VACCINES (2011)
Serotype replacement in disease after pneumococcal vaccination
Daniel M. Weinberger et al.
LANCET (2011)
Horizontal transmission of group B streptococcus in a neonatal intensive care unit
Julia Morinis et al.
PAEDIATRICS & CHILD HEALTH (2011)
Human antibody and memory B and T-cell responses after primary and booster immunisation against Neisseria meningitidis B
Simone C. Cruz et al.
VACCINE (2011)
How Bacterial Carbohydrates Influence the Adaptive Immune System
Fikri Y. Avci et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Laboratory Capacity Building in Asia for Infectious Disease Research: Experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN)
Heiman F. L. Wertheim et al.
PLOS MEDICINE (2010)
Recent advances in understanding the molecular basis of group B Streptococcus virulence
Heather C. Maisey et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
Probiotics: sorting the evidence from the myths
Mimi Pham et al.
MEDICAL JOURNAL OF AUSTRALIA (2008)
Consequences of prophylaxis for group B streptococcal infections of the neonate
Robert S. Baltimore
SEMINARS IN PERINATOLOGY (2007)
Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines
CJ Baker et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen
FYC Lin et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine
CJ Baker et al.
VACCINE (2003)
Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III
CJ Baker et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Level of maternal antibody required to protect neonates against early-onset disease caused by group B streptococcus type Ia: A multicenter, seroepidemiology study
FYC Lin et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Share Paper
